Induction of ribosome methylation in MLS-resistant Streptococcus pneumoniae by macrolides and ketolides

Microbial Drug Resistance

Volumn 5, Issue 3, 1999, Pages 183-188

  Zhong, Ping ^a   Cao, Zhensheng ^a   Hammond, Rachel ^a   Chen, Yan ^a   Beyer, Jill ^a   Shortridge, Virginia D ^a   Phan, L Y ^a   Pratt, Steven ^a   Capobianco, John ^a   Reich, Karl A ^a   Flamm, Robert K ^a   Or, Yat Sun ^a   Katz, Leonard ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; KETOLIDE; LINCOSAMIDE; MACROLIDE; MIKAMYCIN B; TYLOSIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BINDING SITE; DRUG BINDING; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RIBOSOME; RNA METHYLATION; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE;

ILEX COOKII; STREPTOCOCCUS PNEUMONIAE;

EID: 0032755509     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.1999.5.183     Document Type: Article

References (23)

1. Baquero, F., J. Martinez-Beltran, and E. Loza. 1991. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J. Antimicrob. Chemother. 28(suppl. C):31-38.
2. Bonnefoy, A., A.M. Girard, C. Agouridas, and J.F. Chantot. 1997. Ketolides lack inducibility properties of MLS resistance phenotype. J. Antimicrob. Chemother. 40:85-90.
3. Courvalin, P., and C. Carlier. 1986. Transposable multiple antibiotic resistance in Streptococcus pneumoniae. Mol. Gen. Genet. 205:291-297.
4. Dubnau, D. 1985. Induction of ermC requires translation of the leader peptide. EMBO. 4:533-538.
5. Goldman, R., and S. Kadam. 1989. Binding of novel macrolide structures to macrolides-lincosamides-streptogramin B-resistant ribosomes inhibits protein synthesis and bacterial growth. Antimicrob. Agents Chemother. 33:1058-1066.
6. Johnston, N.J., J.C.D. Azavedo, J.D. Kellner, and D.E. Low. 1988. Prevalence and characterization of the mechanisms of macrolide, lincosamide and streptogramin resistance in isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42:2425-2426.
7. Leclercq, R., and P. Courvalin. 1991. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob. Agents Chemother. 35:1267-1272.
8. Mayford, M., and B. Weisblum. 1990. The ermC leader peptide: amino acid alterations leading to differential efficiency of induction by macrolide-lincosamide-streptogramin B antibiotics. J. Bacteriol. 172:3772-3779.
9. Mayford, M., and B. Weisblum. 1985. Messenger RNA from Staphylococcus aureus that specifies macrolide-lincosamide-streptogramin resistance: demonstration of its conformations and of the leader peptide it encodes. J. Mol. Biol. 185:769-80.
10. Murphy, E. 1985. Nucleotide sequence of ermA, a macrolide-lincosamide-streptogramin B determinant in Staphylococcus aureus. J. Bacteriol. 162:633-640.
11. National Committee for Clinical Laboratory Standards (NCCLS) 1998. methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standards, 8th ed. vol. M7 A4. NCCLS, Villanova, Pennsylvania.
12. Oh, T.-G., A.-R. Kwon, and E.-C. Choi. 1998. Induction of ermAMR from a clinical strain of Enterococcus faecalis by 16-membered-ring macrolide antibiotics. J. Bacteriol. 180:5788-5791.
13. Phan, L.T., Y.S. Or, K.P. Spina, Y. Chen, M. Tufano, D.T.W. Chu, A.M. Nilius, M.H. Bui, and J.J. Plattner. 1997. Tricyclic ketolides: mono-substitution on the imine ring. Synthesis and in vitro antibacterial activity, abstr. F-263, p. 190. In Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada.
14. Rosato, A., H. Vicarini, A. Bonnefoy, J.F. Chantot, and R. Leclercq. 1998. A new ketolide, HMR 3004, active against streptococci inducibly resistant to erythromycin. Antimicrob. Agents Chemother. 42:1392-1396.
15. Seppala, H., A. Nissinen, Q. Yu, and P. Huovinen. 1993. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J. Antimicrob. Chemother. 32:885-891.
16. Shivakumar, A.G., and D. Dubnau. 1981. Characterization of a plasmid-specified ribosome methylase associated with macrolide resistance. Nucleic Acids Res. 9:2549-2562.
17. Shortridge, V.D., R.K. Flamm, N. Ramer, J. Beyer, and K. Tanaka. 1996. Novel mechanism of macrolide resistance in Streptococcus pneumoniae. Diagn. Microbiol. Infect. Dis. 26:73-78.
18. Stern, S., D. Moazed, and H.F. Noller. 1988. Structure analysis of RNA using chemical and enzymatic probing monitored by primer extension. Methods Enzymol. 164:481-489.
19. Sutcliffe, J., A. Tait-kamradt, and L. Wondrack. 1996. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40:1817-1824.
20. Tait-Kamradt, A., J. Clancy, M. Cronan, F. Dib-Hajj, L. Wondrack, W. Yuan, and J. Sutcliffe. 1997. MefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41:2251-2255.
21. Weisblum, B. 1995. Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother. 39:577-585.
22. Weisblum, B. 1995. Insights into erythromycin action from studies of its activity as inducer of resistance. Antimicrob. Agents Chemother. 39:797-805.
23. Zhong, P., S.D. Pratt, R.P. Edalji, K.A. Walter, T.F. Holzman, A.G. Shivakumar, and L. Katz. 1995. Substrate requirements for ErmC' methyltransferase activity. J.. Bacteriol. 177:4327-4332.